Huperzine vs Huperzine a for focus
Short answer: For focus, more users report improvement with Huperzine a — 83% of 29 reports, versus 50% of 4 for Huperzine.
Huperzine has 19 meta-analyses and 15 randomized trials on PubMed; Huperzine a has 18 and 14.
Based on 39 reports about Huperzine and 173 about Huperzine a. Not medical advice.
| Huperzine Supplement | Huperzine a Supplement | |
|---|---|---|
| User score | 24 | 49 |
| Verdict | Mixed | Mixed |
| Positive of reports that state an outcome | 50% | 55% |
| Reports | 39 | 173 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 19 / 15 | 18 / 14 |
| Mainly used for | ||
| Focus % reporting improvement | 50% (4) | 83% (29) |
| Energy % reporting improvement | 100% (2) | 100% (6) |
| Sleep % reporting improvement | — | 64% (11) |
| Anxiety % reporting improvement | — | 50% (4) |
| Mood % reporting improvement | — | 50% (4) |
| Memory % reporting improvement | — | 86% (21) |
| Common side effects | unspecified side, brain fog | vivid dreams, nausea, sweating, dizziness |
| Typical dose reported | 100-200 mcg / daily | 200 mcg / 2x |
This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
Front Pharmacol, 2024 ↗“Huperzine and Vinpocetine I have tried only in combination, never exclusively, and have noticed subtle benefits.”
This review suggests that adjunctive HupA is an effective choice for improving cognitive function for patients with schizophrenia spectrum disorders. More well-designed RCTs are needed to further confirm HupA's efficacy. Copyright © 2016 John Wiley & Sons, Ltd.
Hum Psychopharmacol, 2016 ↗“Modafinil, piracetam, huperzine A. Look the shit up”
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate